CoChat

Zeb1 mediates EMT/plasticity-associated ferroptosis sensitivity in cancer cells by regulating lipogenic enzyme expression and phospholipid composition

Open access
Schwab, Annemarie, Rao, Zhigang, Zhang, Jie, Gollowitzer, André, Siebenkäs, Katharina, Bindel, Nino, D’Avanzo, Elisabetta, van Roey, Ruthger, Hajjaj, Yussuf, Özel, Ece, Armstark, Isabell, Bereuter, Leonhard, Su, Fengting, Grander, Julia, Bonyadi Rad, Ehsan, Groenewoud, Arwin, Engel, Felix B., Bell, George W., Henry, Whitney S., Angeli, José Pedro Friedmann, Stemmler, Marc P., Brabletz, Simone, Koeberle, Andreas, Brabletz, Thomas · 2024 · Nature Cell Biology
Cited by 169

The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.

Abstract

Therapy resistance and metastasis, the most fatal steps in cancer, are often triggered by a (partial) activation of the epithelial–mesenchymal transition (EMT) programme. A mesenchymal phenotype predisposes to ferroptosis, a cell death pathway exerted by an iron and oxygen-radical-mediated peroxidation of phospholipids containing polyunsaturated fatty acids. We here show that various forms of EMT activation, including TGFβ stimulation and acquired therapy resistance, increase ferroptosis susceptibility in cancer cells, which depends on the EMT transcription factor Zeb1. We demonstrate that Zeb1 increases the ratio of phospholipids containing pro-ferroptotic polyunsaturated fatty acids over cyto-protective monounsaturated fatty acids by modulating the differential expression of the underlying crucial enzymes stearoyl-Co-A desaturase 1 (SCD), fatty acid synthase (FASN), fatty acid desaturase 2 (FADS2), elongation of very long-chain fatty acid 5 (ELOVL5) and long-chain acyl-CoA synthetase 4 (ACSL4). Pharmacological inhibition of selected lipogenic enzymes (SCD and FADS2) allows the manipulation of ferroptosis sensitivity preferentially in high-Zeb1-expressing cancer cells. Our data are of potential translational relevance and suggest a combination of ferroptosis activators and SCD inhibitors for the treatment of aggressive cancers expressing high Zeb1.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41556-024-01464-1

Cites

15 of 15 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 15 references

Metadata

Authors
Schwab, A., Rao, Z., Zhang, J., Gollowitzer, A., Siebenkäs, K., Bindel, N., D’Avanzo, E., van Roey, R., Hajjaj, Y., Özel, E., Armstark, I., Bereuter, L., Su, F., Grander, J., Bonyadi Rad, E., Groenewoud, A., Engel, F. B., Bell, G. W., Henry, W. S., Angeli, J. P. F., Stemmler, M. P., Brabletz, S., Koeberle, A., & Brabletz, T.
Venue
Nature Cell Biology
Published
2024-07-15
Volume
26
Issue
9
Pages
1470-1481
ISSN
  • 1465-7392 (ISSN-L)
  • 1476-4679
OpenAlex
W4400657725
Cited by
169
References
15
FWCI
43.12
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Zeb1 mediates EMT/plasticity-associated ferroptosis sensitivity in cancer cells by regulating lipogenic enzyme expression and phospholipid composition. https://app.cochat.ai/papers/10.1038/s41556-024-01464-1
The paper
Schwab, A., Rao, Z., Zhang, J., Gollowitzer, A., Siebenkäs, K., Bindel, N., D’Avanzo, E., van Roey, R., Hajjaj, Y., Özel, E., Armstark, I., Bereuter, L., Su, F., Grander, J., Bonyadi Rad, E., Groenewoud, A., Engel, F. B., Bell, G. W., Henry, W. S., . . . Brabletz, T. (2024). Zeb1 mediates EMT/plasticity-associated ferroptosis sensitivity in cancer cells by regulating lipogenic enzyme expression and phospholipid composition. Nature Cell Biology. https://doi.org/10.1038/s41556-024-01464-1

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.